Origen de la red de primer grado Valerie Salentey.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
22
| Public Company | Pharmaceuticals: Major | 22 |
4
| Public Company | Pharmaceuticals: Major | 4 |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France.
2
| Non-Profit Organization | Biotechnology | 2 |
Cytheris SA
 Cytheris SA Pharmaceuticals: MajorHealth Technology Cytheris SA develops and manufactures drugs for immune modulation. It is a clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases. The firm's product CYT107 (glycosylated r-hIL-7), is in clinical development for two targeted indications with urgent medical needs and no current treatments: Progressive Multifocal Leukoencephalopathy (PML) in severely lymphopenic patients and Reduction of complications in Immune Non-Responders with HIV controlled by anti-retroviral treatment (HIV-INR). Cytheris has locations in France and The United States. The company was founded in January 1999 by Michel Morre and is headquartered in Issy-les-Moulineaux, France.
1
| Extinct | Pharmaceuticals: Major | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Valerie Salentey a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Oxford | College/University | Undergraduate Degree | |
| Imperial College London | College/University | Doctorate Degree | |
Haarmann & Reimer Corp
 Haarmann & Reimer Corp Food: Specialty/CandyConsumer Non-Durables Haarmann & Reimer Corp is a German company that manufactures flavors and fragrances. The company is based in Holzminden, DE and has subsidiaries in the United States. Haarmann & Reimer was acquired by EQT III Fund from Bayer AG on October 01, 2002 for $1,676.85 million. | Food: Specialty/Candy | Chairman | |
Amboise Partners SA
 Amboise Partners SA Investment ManagersFinance Apax Partners SA operates as a private equity firm. It invests in technology, media, telecom, retail, healthcare, and business and financial services industries. The company was founded by Maurice Tchenio and Ronald Cohen in 1972 and is headquartered in France. | Investment Managers | Private Equity Investor | |
Ethypharm SAS
 Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | Pharmaceuticals: Major | Director/Board Member | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Director/Board Member Director/Board Member | |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Corporate Officer/Principal | |
| NEXITY | Real Estate Development | Director/Board Member | |
| INSEAD | College/University | Masters Business Admin | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director of Finance/CFO | |
Praxim SA
 Praxim SA Medical SpecialtiesHealth Technology Praxim SA manufactures and sells orthopedic surgical instruments. It specializes in minimal invasive products for knee arthroscopy. The company was founded by Stéphane Lavallée in 1995 and is headquartered in La Tronche, France. | Medical Specialties | Director/Board Member | |
| Sciences Po | College/University | Undergraduate Degree | |
| École Centrale Paris | College/University | Undergraduate Degree | |
| VOLUNTIS S.A. | Packaged Software | Director/Board Member | |
Wittycell SAS
 Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
OMNI Orthopaedics, Inc.
 OMNI Orthopaedics, Inc. Medical SpecialtiesHealth Technology OMNI Orthopaedics, Inc. designs, manufactures, and distributes orthopedic implants. The company was founded by David L. Lasalle, George B. Cipoletti and Edward J. Cheal on December 22, 2008 and is headquartered in Taunton, MA. | Medical Specialties | Director/Board Member | |
Cell Medica Switzerland AG
 Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Bayer SAS
 Bayer SAS Drugstore ChainsRetail Trade Bayer SAS engages in research, development and marketing of pharmaceutical products. The company was founded by Friedrich Bayer and Johann Friedrich Weskott in 1863 and is headquartered in Lyon, France. | Drugstore Chains | Chief Executive Officer | |
| REDX PHARMA PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| École des Hautes Études Commerciales du Nord | College/University | Graduate Degree Undergraduate Degree | |
| BioSupport AG | Corporate Officer/Principal | ||
Invus SAS (Investment Management)
 Invus SAS (Investment Management) Investment ManagersFinance Invus SAS (Investment Management) (Invus-IM) is the investment management division of Invus SAS, a private equity firm headquartered in Paris, France. The firm is owned by The Invus Group LLC in the US. Invus-IM makes equity investments in public companies. | Investment Managers | Analyst-Equity Analyst-Equity | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| AELIS FARMA | Biotechnology | Director/Board Member Director/Board Member | |
| ABIVAX | Pharmaceuticals: Other | Founder Corporate Officer/Principal | |
Mint Solutions Holding BV
 Mint Solutions Holding BV Electronic Equipment/InstrumentsElectronic Technology Mint Solutions Holding BV develops solutions that facilitates medical institutions to control medication. It is a complete closed loop medication safety suite for hospitals and healthcare institutions. The company was founded by Ívar Helgason and Gauti Reynisson in 2009 and is headquartered in Washington, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member | |
| MAAT PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Neovacs, Inc.
 Neovacs, Inc. Pharmaceuticals: MajorHealth Technology Neovacs, Inc. operates as a biotechnology company. It focuses on an active immunotherapy technology platform with applications in autoimmune and inflammatory diseases. The company was founded on March 3, 2015 and is headquartered in Boston, MA. | Pharmaceuticals: Major | President | |
TargEDys SA
 TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member | |
DayTwo Ltd.
 DayTwo Ltd. Medical/Nursing ServicesHealth Services DayTwo Ltd. engages in the provision of glycemic control solution. It focuses on personalized nutrition and actionable insights that allow patient to live healthier, and maintain target blood glucose levels. It offers solutions for employers, clinicians, and patients. The company was founded by Marius Nacht, Yuval Ofek, Lihi Segal, and Yair Schindel in 2015 and is headquartered in Adanim, Israel. | Medical/Nursing Services | Director/Board Member | |
Sensome SAS
 Sensome SAS Electronic Equipment/InstrumentsElectronic Technology Sensome SAS develops remote monitoring invasive vascular medical devices. It focuses on turning invasive medical devices into connected healthcare devices. The company was founded by Franz Bozsak and Abdul Barakat and is headquartered in Massy, France. | Electronic Equipment/Instruments | Director/Board Member | |
| Health Opportunities GmbH | Chief Executive Officer | ||
Siolta Therapeutics, Inc.
 Siolta Therapeutics, Inc. BiotechnologyHealth Technology Siolta Therapeutics, Inc. engages in the development of therapeutic microbial consortia to prevent and treat inflammatory diseases. Its pipeline includes STMC-103H, STMC-144M, and STMC-123R. The company was founded by Susan V. Lynch and Nikole E. Kimes in 2016 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
LiMM Therapeutics SA
 LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Financial Conglomerates | Director/Board Member | |
Plasmaprime SAS
 Plasmaprime SAS Medical/Nursing ServicesHealth Services Plasmaprime SAS provides plasma derived drugs collected from blood transfusion centers. The company was founded by Heriberto Sieler and Philippe Pouletty on January 23, 2009 and is headquartered in Evry, France. | Medical/Nursing Services | Chairman | |
Demeta SAS
 Demeta SAS BiotechnologyHealth Technology Demeta SAS operates as a research and Development in Biotechnology. The firm specializes in biological products, except diagnostic substances. The company was founded in April 4, 2011 and is headquartered in Paris, France. | Biotechnology | Chairman | |
Natchem SAS
 Natchem SAS BiotechnologyHealth Technology NatChem SAS engages in research and development, which focuses on biotechnology. The company was founded on December 2011 and is headquartered in Paris, France. | Biotechnology | Chairman |
Estadísticas
Internacional
| Francia | 30 |
| Estados Unidos | 7 |
| Suiza | 6 |
| Reino Unido | 5 |
| Israel | 3 |
Sectorial
| Health Technology | 24 |
| Finance | 9 |
| Consumer Services | 8 |
| Commercial Services | 3 |
| Electronic Technology | 3 |
Operativa
| Director/Board Member | 136 |
| Chairman | 45 |
| Corporate Officer/Principal | 42 |
| Independent Dir/Board Member | 28 |
| Chief Executive Officer | 22 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Edwin Moses | 35 |
| David Lawrence | 29 |
| François Thomas | 25 |
| Miguel Sieler | 25 |
| Patrick J. Langlois | 23 |
| Eric Forquenot de la Fortelle | 19 |
| Scott Myers | 18 |
| Khalil Barrage | 15 |
| Florian Reinaud | 15 |
| Cédric Moreau | 14 |
| Fulvio Mavilio | 10 |
| Jean-François Morin | 10 |
| Nawal Ouzren | 9 |
| John Furey | 9 |
| Aniz Girach | 7 |
- Bolsa de valores
- Insiders
- Valerie Salentey
- Conexiones Empresas
